Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TAX1BP1-AS1 is a long non-coding RNA transcribed antisense to the TAX1BP1 gene locus. While the TAX1BP1 protein acts as a crucial regulator of autophagy, ubiquitin-mediated signaling, NF-κB pathway termination, and host defense, the antisense RNA TAX1BP1-AS1 itself has not been characterized functionally or therapeutically. There is currently no evidence for its direct involvement in disease, drug interactions, or use as a therapeutic target. Future studies may clarify any functional role TAX1BP1-AS1 may have in regulating its sense gene or in pathological states, but presently its molecular and clinical significance is unknown[2][6]. If you intended the query for the TAX1BP1 protein (Tax1 binding protein 1), please clarify; this answer specifically refers to the antisense RNA “TAX1BP1-AS1.” All results and known functions reference the protein/gene, not the antisense transcript.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TAX1BP1 antisense RNA 1 (TAX1BP1-AS1).